1-3 of 3
Susanne Danhauser-Riedl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NOTCH1 Mutation and Treatment Outcome In CLL Patients Treated With Chlorambucil (Chl) Or Ofatumumab-Chl (O-Chl): Results From The Phase III Study Complement 1 (OMB110911)

Eugen Tausch, MD, Philipp Beck, Richard F. Schlenk, MD, Sabrina Kless, Christina Galler, Peter Hillmen, MB ChB, PhD, Fritz Offner, MD, Ann Janssens, MD, K Govindbabu, MD, Sebastian Grosicki, MD, Jiri Mayer, MD, PhD, Panagiotis Panagiotidis, MD, Susanne Danhauser-Riedl, MD, Astrid McKeown, PhD, Paul D P´B Winter, PhD, Ira V Gupta, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2013) 122 (21): 527.
https://doi.org/10.1182/blood.V122.21.527.527
Published: 2013
Journal Articles

The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate

Christine Schuster, Karin Forster, Henning Dierks, Annika Elsässer, Gerhard Behre, Nicola Simon, Susanne Danhauser-Riedl, Michael Hallek, Markus Warmuth
Journal: Blood
Blood (2003) 101 (2): 655–663.
https://doi.org/10.1182/blood-2002-01-0043
Published: 2003
Journal Articles

Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors

Clemens-Martin Wendtner, David M. Kofler, Hans D. Theiss, Christian Kurzeder, Raymund Buhmann, Carmen Schweighofer, Luca Perabo, Susanne Danhauser-Riedl, Jens Baumert, Wolfgang Hiddemann, Michael Hallek, Hildegard Büning
Journal: Blood
Blood (2002) 100 (5): 1655–1661.
https://doi.org/10.1182/blood.V100.5.1655.h81702001655_1655_1661
Published: 2002